Cargando…

Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway

Nasopharyngeal carcinoma (NPC) is a prevalent malignancy in Southeast Asia and Southern China. Laminin subunit beta-3 (LAMB3) has been validated to participate in diverse cancers. Nevertheless, the role and mechanism of LAMB3 in NPC remain unclear. In this study, LAMB3 expression is upregulated in N...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Qianru, Liu, Guolong, Huang, Wenqiang, He, Zhijiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214995/
https://www.ncbi.nlm.nih.gov/pubmed/36947579
http://dx.doi.org/10.1093/jrr/rrad014
_version_ 1785047958767534080
author Zhuang, Qianru
Liu, Guolong
Huang, Wenqiang
He, Zhijiang
author_facet Zhuang, Qianru
Liu, Guolong
Huang, Wenqiang
He, Zhijiang
author_sort Zhuang, Qianru
collection PubMed
description Nasopharyngeal carcinoma (NPC) is a prevalent malignancy in Southeast Asia and Southern China. Laminin subunit beta-3 (LAMB3) has been validated to participate in diverse cancers. Nevertheless, the role and mechanism of LAMB3 in NPC remain unclear. In this study, LAMB3 expression is upregulated in NPC cells and tissues. Interestingly, knockdown of LAMB3 promoted apoptosis and reduced the radioresistance of NPC cells. Besides, shLAMB3 enhanced X-ray-induced reactive oxygen species (ROS) accumulation. Mechanically, knockdown of LAMB3 deactivated nuclear factor erythroid-2-related factor 2 (NRF2) signaling pathway via enhancing forkhead box 3 (FOXO3) expression. In rescue experiments, suppression of NRF2 signaling pathway abrogated shLAMB3-induced NPC cell apoptosis and ROS accumulation under X-ray treatment. Similarly, LAMB3 knockdown restrains NPC tumor growth and reduces radioresistance in vivo. Thus, these findings concluded that knockdown of LAMB3 enhanced apoptosis and ROS accumulation, and suppressed radioresistance in NPC via enhancing FOXO3 expression and deactivating NRF2 signaling pathway, facilitating the development of novel strategies for NPC radioresistance.
format Online
Article
Text
id pubmed-10214995
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102149952023-05-27 Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway Zhuang, Qianru Liu, Guolong Huang, Wenqiang He, Zhijiang J Radiat Res Regular paper Nasopharyngeal carcinoma (NPC) is a prevalent malignancy in Southeast Asia and Southern China. Laminin subunit beta-3 (LAMB3) has been validated to participate in diverse cancers. Nevertheless, the role and mechanism of LAMB3 in NPC remain unclear. In this study, LAMB3 expression is upregulated in NPC cells and tissues. Interestingly, knockdown of LAMB3 promoted apoptosis and reduced the radioresistance of NPC cells. Besides, shLAMB3 enhanced X-ray-induced reactive oxygen species (ROS) accumulation. Mechanically, knockdown of LAMB3 deactivated nuclear factor erythroid-2-related factor 2 (NRF2) signaling pathway via enhancing forkhead box 3 (FOXO3) expression. In rescue experiments, suppression of NRF2 signaling pathway abrogated shLAMB3-induced NPC cell apoptosis and ROS accumulation under X-ray treatment. Similarly, LAMB3 knockdown restrains NPC tumor growth and reduces radioresistance in vivo. Thus, these findings concluded that knockdown of LAMB3 enhanced apoptosis and ROS accumulation, and suppressed radioresistance in NPC via enhancing FOXO3 expression and deactivating NRF2 signaling pathway, facilitating the development of novel strategies for NPC radioresistance. Oxford University Press 2023-03-22 /pmc/articles/PMC10214995/ /pubmed/36947579 http://dx.doi.org/10.1093/jrr/rrad014 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Regular paper
Zhuang, Qianru
Liu, Guolong
Huang, Wenqiang
He, Zhijiang
Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway
title Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway
title_full Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway
title_fullStr Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway
title_full_unstemmed Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway
title_short Knockdown of LAMB3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating NRF2 signaling pathway
title_sort knockdown of lamb3 suppressed radioresistance in nasopharyngeal carcinoma via deactivating nrf2 signaling pathway
topic Regular paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214995/
https://www.ncbi.nlm.nih.gov/pubmed/36947579
http://dx.doi.org/10.1093/jrr/rrad014
work_keys_str_mv AT zhuangqianru knockdownoflamb3suppressedradioresistanceinnasopharyngealcarcinomaviadeactivatingnrf2signalingpathway
AT liuguolong knockdownoflamb3suppressedradioresistanceinnasopharyngealcarcinomaviadeactivatingnrf2signalingpathway
AT huangwenqiang knockdownoflamb3suppressedradioresistanceinnasopharyngealcarcinomaviadeactivatingnrf2signalingpathway
AT hezhijiang knockdownoflamb3suppressedradioresistanceinnasopharyngealcarcinomaviadeactivatingnrf2signalingpathway